Carmichael Hill & Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $420 | Hold |
5
| – | – | ﹤0.01% | 642 |
|
|
2024
Q2 | $344 | Hold |
5
| – | – | ﹤0.01% | 652 |
|
|
2024
Q1 | $367 | Hold |
5
| – | – | ﹤0.01% | 654 |
|
|
2023
Q4 | $406 | Hold |
5
| – | – | ﹤0.01% | 657 |
|
|
2023
Q3 | $375 | Hold |
5
| – | – | ﹤0.01% | 656 |
|
|
2023
Q2 | $386 | Sell |
5
-63
| -93% | -$4.86K | ﹤0.01% | 659 |
|
|
2023
Q1 | $5.64K | Buy |
68
+63
| +1,260% | +$5.23K | ﹤0.01% | 535 |
|
|
2022
Q4 | $429 | Hold |
5
| – | – | ﹤0.01% | 638 |
|
|
2022
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 737 |
|
|
2022
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 734 |
|
|
2022
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 701 |
|
|
2021
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 701 |
|
|
2021
Q3 | $0 | Buy |
+5
| New | – | ﹤0.01% | 695 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 679 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 666 |
|
|
2020
Q4 | – | Sell |
-125
| Closed | -$8K | – | 657 |
|
|
2020
Q3 | $8K | Sell |
125
-40
| -24% | -$2.56K | 0.01% | 458 |
|
|
2020
Q2 | $13K | Buy |
165
+50
| +43% | +$3.94K | 0.01% | 387 |
|
|
2020
Q1 | $9K | Sell |
115
-148
| -56% | -$11.6K | 0.01% | 403 |
|
|
2019
Q4 | $17K | Buy |
+263
| New | +$17K | 0.01% | 357 |
|